Table 5.
Survival analysis by age at diagnosis, by number of metastatic sites
| Age at diagnosis | Number of patients | Median survival (days) | 95% CI |
|---|---|---|---|
| <50 years | 91 | 291 | 260.41–321.59 |
| 50–60 years | 245 | 288 | 256.09–319.91 |
| 60–70 years | 334 | 282 | 256.93–307.07 |
| >70 years | 94 | 273 | 228.95–317.05 |
| Number of different metastatic sites | |||
| 0 | 395 | 334 | 307.87–360.13 |
| 1 | 270 | 251 | 228.99–273.01 |
| 2 | 88 | 180 | 128.52–231.48 |
| 3 | 11 | 152 | 67.57–236.43 |
| Total | 764 | 286 | 270.47–301.53 |
| Metastatic sites | |||
| Bone | 97 | 272 | 228.13–315.87 |
| Brain | 44 | 239 | 198.91–279.09 |
| Liver | 92 | 212 | 171.58–252.42 |
| Adrenal | 24 | 297 | 270.59–323.40 |
| Total | 257 | 249 | 225.72–272.27 |
Abbreviation: CI, confidence interval.